Information Journal Paper
APA:
Copy. (2021). Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells. FRONTIERS IN IMMUNOLOGY, 12(-), 0-0. SID. https://sid.ir/paper/1083114/en
Vancouver:
Copy. Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells. FRONTIERS IN IMMUNOLOGY[Internet]. 2021;12(-):0-0. Available from: https://sid.ir/paper/1083114/en
IEEE:
Copy, “Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells,” FRONTIERS IN IMMUNOLOGY, vol. 12, no. -, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/1083114/en